These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 444361)

  • 21. Isoniazid pharmacokinetics in patients in chronic renal failure.
    Gold CH; Buchanan N; Tringham V; Viljoen M; Strickwold B; Moodley GP
    Clin Nephrol; 1976 Aug; 6(2):365-9. PubMed ID: 954244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciprofloxacin and oxociprofloxacin pharmacokinetics in patients on haemodialysis.
    Drinovec J; Mrhar A; Bren A; Primozic S; Karba R; Varl J; Kozjek F
    J Chemother; 1989 Jul; 1(4 Suppl):565-6. PubMed ID: 16312534
    [No Abstract]   [Full Text] [Related]  

  • 23. Verapamil kinetics during maintenance hemodialysis.
    Shah GM; Winer RL
    Am J Nephrol; 1985; 5(5):338-41. PubMed ID: 4061502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum clofibrate concentrations in patients on continuous medication.
    Faed EM; McQueen EG
    Pharmacology; 1974; 12(3):144-51. PubMed ID: 4475428
    [No Abstract]   [Full Text] [Related]  

  • 25. Bioavailability studies of etofibrate in rhesus monkeys.
    Waller AR; Chasseaud LF; Taylor T; Schatton W
    Arzneimittelforschung; 1985; 35(2):489-92. PubMed ID: 4039571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of clofibrate toxicity in uremic hypertriglyceridemia.
    Goldberg AP; Sherrard DJ; Haas LB; Brunzell JD
    Clin Pharmacol Ther; 1977 Mar; 21(3):317-25. PubMed ID: 837651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic aspects of digoxin in patients with terminal renal failure. II. On hemodialysis.
    van der Vijgh WJ
    Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):255-9. PubMed ID: 881277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A studyof the pharmacokinetics of clidamycin in normal subjects and patients with chronic renal failure.
    Eastwood JB; Gower PE
    Postgrad Med J; 1974 Nov; 50(589):710-2. PubMed ID: 4467873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacology of propylthiouracil in thyrotoxicosis and chronic renal failure.
    Cooper DS; Steigerwalt S; Migdal S
    Arch Intern Med; 1987 Apr; 147(4):785-6. PubMed ID: 3827468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of hemodialysis on the pharmacokinetics of theophylline in chronic renal failure.
    Kradjan WA; Martin TR; Delaney CJ; Blair AD; Cutler RE
    Nephron; 1982; 32(1):40-4. PubMed ID: 7177275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin elimination and hemostasis in hemodialysis.
    Wilhelmsson S; Lins LE
    Clin Nephrol; 1984 Dec; 22(6):303-6. PubMed ID: 6525772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A quantitative gaschromatographic method for the determination of p-chlorophenoxyisobutyric acid (clofibrinic acid) in human plasma (author's transl)].
    Häselbarth V
    Arzneimittelforschung; 1976; 26(11):2076-80. PubMed ID: 1037251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasma acetate and bicarbonate kinetics and intolerance to acetate during and after renal dialysis].
    Bruno R; Grandvuillemin M; Olmer M; Cano JP
    Pathol Biol (Paris); 1984 Sep; 32(7):768-71. PubMed ID: 6493812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of fosfomycin in hemodialyzed patients.
    Bouchet JL; Quentin C; Albin H; Vinçon G; Guillon J; Martin-Dupont P
    Clin Nephrol; 1985 May; 23(5):218-21. PubMed ID: 4006330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinogen kinetics in chronic renal failure of various causes.
    Ardaillou N; Sraer JD; Beaufils P
    Biomedicine; 1974 Jan; 21(1):49-56. PubMed ID: 4844175
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of hemodialysis on serum concentration of isepamicin in a patient with endstage renal failure.
    Kuranari M; Nawata T; Sato Y; Sakata T; Kodama Y; Takeyama M
    Ann Pharmacother; 1993 Oct; 27(10):1284-5. PubMed ID: 8251702
    [No Abstract]   [Full Text] [Related]  

  • 37. [Parenteral administration of a new cephalosporin in patients with chronic kidney failure. Study of plasmatic half-life of the antibiotic in relation to glomerular clearance].
    Malandain H; Humbert G; Fillastre JP; Acar J; Dubois D; Leroy J; Robert M; Daufresne MF
    Pathol Biol (Paris); 1973 Mar; 21(3):233-9. PubMed ID: 4574486
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study, by means of a spectrofluorometric method, of plasma concentrations of doxycycline and of the elimination of this antibiotic in urine or dialysis fluid in patients with severe chronic kidney failure].
    Gavend M; Muller JM; Bessard G; Meftahi H; Debru JL; Cordonnier D
    Therapie; 1972; 27(5):925-36. PubMed ID: 4651413
    [No Abstract]   [Full Text] [Related]  

  • 39. Minocycline and doxycycline kinetics in chronic renal failure.
    Heaney D; Eknoyan G
    Clin Pharmacol Ther; 1978 Aug; 24(2):233-9. PubMed ID: 679601
    [No Abstract]   [Full Text] [Related]  

  • 40. Clofibrate and clofibric acid: comparison of the metabolic disposition in rats and dogs.
    Cayen MN; Ferdinandi ES; Greselin E; Robinson WT; Dvornik D
    J Pharmacol Exp Ther; 1977 Jan; 200(1):33-43. PubMed ID: 833760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.